Global Vermox Market Growth (Status and Outlook) 2022-2028
- LP 4857317
- 88 Pages
- February 2022
- Pharmaceuticals
The United States Vermox market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vermox market, reaching US$ million by the year 2028. As for the Europe Vermox landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vermox players cover Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, and Eipico, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vermox market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Tablet
Oral Suspension
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Children
Adult
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vermox Market Size 2017-2028
2.1.2 Vermox Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Vermox Segment by Type
2.2.1 Tablet
2.2.2 Oral Suspension
2.3 Vermox Market Size by Type
2.3.1 Vermox Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Vermox Market Size Market Share by Type (2017-2022)
2.4 Vermox Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Vermox Market Size by Application
2.5.1 Vermox Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Vermox Market Size Market Share by Application (2017-2022)
3 Vermox Market Size by Player
3.1 Vermox Market Size Market Share by Players
3.1.1 Global Vermox Revenue by Players (2020-2022)
3.1.2 Global Vermox Revenue Market Share by Players (2020-2022)
3.2 Global Vermox Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Vermox by Regions
4.1 Vermox Market Size by Regions (2017-2022)
4.2 Americas Vermox Market Size Growth (2017-2022)
4.3 APAC Vermox Market Size Growth (2017-2022)
4.4 Europe Vermox Market Size Growth (2017-2022)
4.5 Middle East & Africa Vermox Market Size Growth (2017-2022)
5 Americas
5.1 Americas Vermox Market Size by Country (2017-2022)
5.2 Americas Vermox Market Size by Type (2017-2022)
5.3 Americas Vermox Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vermox Market Size by Region (2017-2022)
6.2 APAC Vermox Market Size by Type (2017-2022)
6.3 APAC Vermox Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Vermox by Country (2017-2022)
7.2 Europe Vermox Market Size by Type (2017-2022)
7.3 Europe Vermox Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vermox by Region (2017-2022)
8.2 Middle East & Africa Vermox Market Size by Type (2017-2022)
8.3 Middle East & Africa Vermox Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Vermox Market Forecast
10.1 Global Vermox Forecast by Regions (2023-2028)
10.1.1 Global Vermox Forecast by Regions (2023-2028)
10.1.2 Americas Vermox Forecast
10.1.3 APAC Vermox Forecast
10.1.4 Europe Vermox Forecast
10.1.5 Middle East & Africa Vermox Forecast
10.2 Americas Vermox Forecast by Country (2023-2028)
10.2.1 United States Vermox Market Forecast
10.2.2 Canada Vermox Market Forecast
10.2.3 Mexico Vermox Market Forecast
10.2.4 Brazil Vermox Market Forecast
10.3 APAC Vermox Forecast by Region (2023-2028)
10.3.1 China Vermox Market Forecast
10.3.2 Japan Vermox Market Forecast
10.3.3 Korea Vermox Market Forecast
10.3.4 Southeast Asia Vermox Market Forecast
10.3.5 India Vermox Market Forecast
10.3.6 Australia Vermox Market Forecast
10.4 Europe Vermox Forecast by Country (2023-2028)
10.4.1 Germany Vermox Market Forecast
10.4.2 France Vermox Market Forecast
10.4.3 UK Vermox Market Forecast
10.4.4 Italy Vermox Market Forecast
10.4.5 Russia Vermox Market Forecast
10.5 Middle East & Africa Vermox Forecast by Region (2023-2028)
10.5.1 Egypt Vermox Market Forecast
10.5.2 South Africa Vermox Market Forecast
10.5.3 Israel Vermox Market Forecast
10.5.4 Turkey Vermox Market Forecast
10.5.5 GCC Countries Vermox Market Forecast
10.6 Global Vermox Forecast by Type (2023-2028)
10.7 Global Vermox Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Information
11.1.2 Johnson & Johnson Vermox Product Offered
11.1.3 Johnson & Johnson Vermox Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Johnson & Johnson Main Business Overview
11.1.5 Johnson & Johnson Latest Developments
11.2 Amneal Pharmaceuticals
11.2.1 Amneal Pharmaceuticals Company Information
11.2.2 Amneal Pharmaceuticals Vermox Product Offered
11.2.3 Amneal Pharmaceuticals Vermox Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Amneal Pharmaceuticals Main Business Overview
11.2.5 Amneal Pharmaceuticals Latest Developments
11.3 Cadila Pharmaceuticals
11.3.1 Cadila Pharmaceuticals Company Information
11.3.2 Cadila Pharmaceuticals Vermox Product Offered
11.3.3 Cadila Pharmaceuticals Vermox Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Cadila Pharmaceuticals Main Business Overview
11.3.5 Cadila Pharmaceuticals Latest Developments
11.4 Eipico
11.4.1 Eipico Company Information
11.4.2 Eipico Vermox Product Offered
11.4.3 Eipico Vermox Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Eipico Main Business Overview
11.4.5 Eipico Latest Developments
11.5 Esteve Pharmaceuticals
11.5.1 Esteve Pharmaceuticals Company Information
11.5.2 Esteve Pharmaceuticals Vermox Product Offered
11.5.3 Esteve Pharmaceuticals Vermox Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Esteve Pharmaceuticals Main Business Overview
11.5.5 Esteve Pharmaceuticals Latest Developments
11.6 Tenry
11.6.1 Tenry Company Information
11.6.2 Tenry Vermox Product Offered
11.6.3 Tenry Vermox Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Tenry Main Business Overview
11.6.5 Tenry Latest Developments
12 Research Findings and Conclusion
Table 1. Vermox Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Tablet
Table 3. Major Players of Oral Suspension
Table 4. Vermox Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Vermox Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Vermox Market Size Market Share by Type (2017-2022)
Table 7. Vermox Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Vermox Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Vermox Market Size Market Share by Application (2017-2022)
Table 10. Global Vermox Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Vermox Revenue Market Share by Player (2020-2022)
Table 12. Vermox Key Players Head office and Products Offered
Table 13. Vermox Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Vermox Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Vermox Market Size Market Share by Regions (2017-2022)
Table 18. Americas Vermox Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Vermox Market Size Market Share by Country (2017-2022)
Table 20. Americas Vermox Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Vermox Market Size Market Share by Type (2017-2022)
Table 22. Americas Vermox Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Vermox Market Size Market Share by Application (2017-2022)
Table 24. APAC Vermox Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Vermox Market Size Market Share by Region (2017-2022)
Table 26. APAC Vermox Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Vermox Market Size Market Share by Type (2017-2022)
Table 28. APAC Vermox Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Vermox Market Size Market Share by Application (2017-2022)
Table 30. Europe Vermox Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Vermox Market Size Market Share by Country (2017-2022)
Table 32. Europe Vermox Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Vermox Market Size Market Share by Type (2017-2022)
Table 34. Europe Vermox Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Vermox Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Vermox Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Vermox Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Vermox Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Vermox Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Vermox Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Vermox Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Vermox
Table 43. Key Market Challenges & Risks of Vermox
Table 44. Key Industry Trends of Vermox
Table 45. Global Vermox Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Vermox Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Vermox Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Vermox Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Vermox Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Vermox Market Size Market Share Forecast by Application (2023-2028)
Table 51. Johnson & Johnson Details, Company Type, Vermox Area Served and Its Competitors
Table 52. Johnson & Johnson Vermox Product Offered
Table 53. Johnson & Johnson Vermox Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Johnson & Johnson Main Business
Table 55. Johnson & Johnson Latest Developments
Table 56. Amneal Pharmaceuticals Details, Company Type, Vermox Area Served and Its Competitors
Table 57. Amneal Pharmaceuticals Vermox Product Offered
Table 58. Amneal Pharmaceuticals Main Business
Table 59. Amneal Pharmaceuticals Vermox Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Amneal Pharmaceuticals Latest Developments
Table 61. Cadila Pharmaceuticals Details, Company Type, Vermox Area Served and Its Competitors
Table 62. Cadila Pharmaceuticals Vermox Product Offered
Table 63. Cadila Pharmaceuticals Main Business
Table 64. Cadila Pharmaceuticals Vermox Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Cadila Pharmaceuticals Latest Developments
Table 66. Eipico Details, Company Type, Vermox Area Served and Its Competitors
Table 67. Eipico Vermox Product Offered
Table 68. Eipico Main Business
Table 69. Eipico Vermox Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Eipico Latest Developments
Table 71. Esteve Pharmaceuticals Details, Company Type, Vermox Area Served and Its Competitors
Table 72. Esteve Pharmaceuticals Vermox Product Offered
Table 73. Esteve Pharmaceuticals Main Business
Table 74. Esteve Pharmaceuticals Vermox Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Esteve Pharmaceuticals Latest Developments
Table 76. Tenry Details, Company Type, Vermox Area Served and Its Competitors
Table 77. Tenry Vermox Product Offered
Table 78. Tenry Main Business
Table 79. Tenry Vermox Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Tenry Latest Developments
List of Figures
Figure 1. Vermox Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vermox Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Vermox Market Size Market Share by Type in 2021
Figure 7. Vermox in Children
Figure 8. Global Vermox Market: Children (2017-2022) & ($ Millions)
Figure 9. Vermox in Adult
Figure 10. Global Vermox Market: Adult (2017-2022) & ($ Millions)
Figure 11. Global Vermox Market Size Market Share by Application in 2021
Figure 12. Global Vermox Revenue Market Share by Player in 2021
Figure 13. Global Vermox Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Vermox Market Size 2017-2022 ($ Millions)
Figure 15. APAC Vermox Market Size 2017-2022 ($ Millions)
Figure 16. Europe Vermox Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Vermox Market Size 2017-2022 ($ Millions)
Figure 18. Americas Vermox Value Market Share by Country in 2021
Figure 19. Americas Vermox Consumption Market Share by Type in 2021
Figure 20. Americas Vermox Market Size Market Share by Application in 2021
Figure 21. United States Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Vermox Market Size Market Share by Region in 2021
Figure 26. APAC Vermox Market Size Market Share by Application in 2021
Figure 27. China Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Vermox Market Size Market Share by Country in 2021
Figure 34. Europe Vermox Market Size Market Share by Type in 2021
Figure 35. Europe Vermox Market Size Market Share by Application in 2021
Figure 36. Germany Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Vermox Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Vermox Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Vermox Market Size Market Share by Application in 2021
Figure 44. Egypt Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Vermox Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Vermox Market Size 2023-2028 ($ Millions)
Figure 50. APAC Vermox Market Size 2023-2028 ($ Millions)
Figure 51. Europe Vermox Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Vermox Market Size 2023-2028 ($ Millions)
Figure 53. United States Vermox Market Size 2023-2028 ($ Millions)
Figure 54. Canada Vermox Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Vermox Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Vermox Market Size 2023-2028 ($ Millions)
Figure 57. China Vermox Market Size 2023-2028 ($ Millions)
Figure 58. Japan Vermox Market Size 2023-2028 ($ Millions)
Figure 59. Korea Vermox Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Vermox Market Size 2023-2028 ($ Millions)
Figure 61. India Vermox Market Size 2023-2028 ($ Millions)
Figure 62. Australia Vermox Market Size 2023-2028 ($ Millions)
Figure 63. Germany Vermox Market Size 2023-2028 ($ Millions)
Figure 64. France Vermox Market Size 2023-2028 ($ Millions)
Figure 65. UK Vermox Market Size 2023-2028 ($ Millions)
Figure 66. Italy Vermox Market Size 2023-2028 ($ Millions)
Figure 67. Russia Vermox Market Size 2023-2028 ($ Millions)
Figure 68. Spain Vermox Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Vermox Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Vermox Market Size 2023-2028 ($ Millions)
Figure 71. Israel Vermox Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Vermox Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Vermox Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
